Instil Bio, Inc. (TIL)

NASDAQ: TIL · IEX Real-Time Price · USD
0.405
-0.007 (-1.79%)
Sep 28, 2023, 9:30 AM EDT - Market open

Income Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120202019
Revenue
000.140
Gross Profit
000.140
Selling, General & Admin
62.2448.3114.382.56
Research & Development
141.06107.2519.44.03
Other Operating Expenses
23.17000
Operating Expenses
226.46155.5633.786.59
Operating Income
-226.46-155.56-33.64-6.59
Interest Expense / Income
1.88000
Other Expense / Income
-3.091.23.94-0.06
Pretax Income
-225.25-156.76-37.59-6.52
Income Tax
-2.070.040.150
Net Income
-223.18-156.79-37.74-6.52
Shares Outstanding (Basic)
1301061612
Shares Outstanding (Diluted)
1301061612
Shares Change
22.19%562.55%35.04%-
EPS (Basic)
-1.72-1.48-2.36-0.55
EPS (Diluted)
-1.72-1.48-2.36-0.55
Free Cash Flow
-264.75-179.97-80.43-5.5
Free Cash Flow Per Share
-2.04-1.70-5.03-0.47
Gross Margin
--100.00%-
Operating Margin
---24379.71%-
Profit Margin
---27346.38%-
Free Cash Flow Margin
---58284.06%-
EBITDA
-215.62-154-37.33-6.5
EBITDA Margin
---27051.45%-
Depreciation & Amortization
7.752.750.260.02
EBIT
-223.37-156.76-37.59-6.52
EBIT Margin
---27236.96%-
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).